Is Merck & Co. Inc. a Buy?
If 2017 ended right now, it would be the worst year for Merck & Co. (NYSE: MRK) stock since the financial crisis of 2008. There are still several weeks remaining before the year ends, of course, but the big pharma stock is down at a time when most of its peers are performing quite well.
While some declines in stock valuations reflect long-term problems, others are only temporary. Which is the case for Merck? Here are arguments for and against buying the stock right now -- and which argument is stronger.
Image source: Getty Images.
Source: Fool.com
Merck & Co. Inc. Stock
€111.22
-0.340%
With 25 Buy predictions and not a single Sell prediction Merck & Co. Inc. is an absolute favorite of our community.
With a target price of 122 € there is a slightly positive potential of 9.69% for Merck & Co. Inc. compared to the current price of 111.22 €.
